New radiation drug trial offers hope for Tough-to-Treat gut cancers
Disease control
Recruiting now
This study is testing whether a new radioactive drug called RYZ101 works better than standard treatments for advanced neuroendocrine tumors of the gut and pancreas. It's for people whose tumors have grown despite previous radiation therapy. The trial will measure how long the dru…
Phase: PHASE3 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC